GlaxoSmithKline
GSK
50.33
-0.08
-0.16%
GlaxoSmithKline
US · GSK
#230 by market cap
Listed 1970
50.33
-0.08
-0.16%
Periodic snapshot; not a real-time feed.
· 2026-11-06 19:30
About GlaxoSmithKline
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.
- CEO
- Mr. Luke Miels
- Employees
- 66,841
- Headquarters
- London, Greater London, United Kingdom of Great Britain and Northern Ireland (the)
- Fiscal year end
- 12-31
- Website
- gsk.com
Company profile
- Exchange
- US
- Symbol
- GSK
- Market-cap rank
- #230
- Listing date
- 1970-01-01
- Market cap
- 100.88B
- Float cap
- 97.78B
- Shares out
- 2.00B
- Float shares
- 1.94B
Sectors & themes
Quote time 2026-11-06 19:30:03 · For reference only, not investment advice and not tailored to your situation.
GlaxoSmithKline discussion 0 comments